| C10AA05 |
Atorvastatin |
Atorvastatin Ecopharm |
Film coated tablet |
10 |
mg |
30 |
Екофарм Груп АД, България |
20 |
mg |
- |
2.5 |
0.08333 |
1.25 |
25% |
0.31 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-12134/27.03.2017; КП-62/10.08.2018 и НСР-15887/15.06.2018; НСР-16737/07.09.2018 |
02.10.2018 |
|
|
Заличен |
15639 |
| C10AA05 |
Atorvastatin |
ATORVASTATIN GENERICON |
Film coated tablet |
10 |
mg |
30 |
Genericon Pharma GmbH, Австрия |
20 |
mg |
- |
8.68 |
0.08333 |
1.25 |
25% |
0.31 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№ 199/ 20.09.2011; НСР-17001/12.10.2018 |
02.11.2018 |
08.09.2012 |
|
Заличен |
1076 |
| C10AA05 |
Atorvastatin |
ATORVASTATIN GENERICON |
Film coated tablet |
20 |
mg |
30 |
Genericon Pharma GmbH, Австрия |
20 |
mg |
- |
16.96 |
0.08333 |
2.5 |
25% |
0.62 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№ 199/ 20.09.2011; НСР-17001/12.10.2018 |
02.11.2018 |
08.09.2012 |
|
Заличен |
1077 |
| C10AA05 |
Atorvastatin |
Atorvin |
Film coated tablet |
40 |
mg |
30 |
Нобел Фарма ЕООД, България |
20 |
mg |
- |
10 |
0.08333 |
5 |
25% |
1.25 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-978/16.08.2013; НСР-17206/09.11.2018 |
02.12.2018 |
|
|
Активен |
2081 |
| C10AA05 |
Atorvastatin |
Atorvin |
Film coated tablet |
20 |
mg |
30 |
Нобел Фарма ЕООД, България |
20 |
mg |
- |
5 |
0.08333 |
2.5 |
25% |
0.62 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-978/16.08.2013; НСР-17207/09.11.2018 |
02.12.2018 |
|
|
Активен |
2080 |
| C10AA05 |
Atorvastatin |
Atorvin |
Film coated tablet |
10 |
mg |
30 |
Нобел Фарма ЕООД, България |
20 |
mg |
- |
2.5 |
0.08333 |
1.25 |
25% |
0.31 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-978/16.08.2013; НСР-17208/09.11.2018 |
02.12.2018 |
|
|
Активен |
2079 |
| C10AA05 |
Atorvastatin |
Atorvin |
Film coated tablet |
80 |
mg |
30 |
Нобел Фарма ЕООД, България |
20 |
mg |
- |
19.52 |
0.08333 |
10 |
25% |
2.5 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-978/16.08.2013; НСР-17159/01.11.2018; НСР-17211/09.11.2018 |
02.12.2018 |
|
|
Заличен |
2082 |
| C10AA05 |
Atorvastatin |
ATORVISTAT |
Film coated tablet |
10 |
mg |
30 |
Унифарм АД, България |
20 |
mg |
- |
7.33 |
0.12033 |
1.81 |
25% |
0.45 |
|
I20,I25.5,I69 |
№ 117/10.11.2010; КЦРР-2066/24.01.2013 г; НСР-1114/04.09.2013 |
02.10.2013 |
08.09.2012 |
|
Заличен |
1582 |
| C10AA05 |
Atorvastatin |
ATORVISTAT |
Film coated tablet |
20 |
mg |
30 |
Унифарм АД, България |
20 |
mg |
- |
17.11 |
0.12033 |
3.61 |
25% |
0.9 |
|
I20,I25.5,I69 |
№ 117/10.11.2010; НСР-1115/04.09.2013 |
02.10.2013 |
08.09.2012 |
|
Заличен |
959 |
| C10AA05 |
Atorvastatin |
Atorvistat K |
Film coated tablet |
20 |
mg |
30 |
Софарма АД, България |
20 |
mg |
- |
7.18 |
0.08333 |
2.5 |
25% |
0.62 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
КЦРР-2742/20.03.2013 г.; НСР-8527/16.03.2016; НСР-18407/05.04.2019 |
02.05.2019 |
|
|
Активен |
1769 |
| C10AA05 |
Atorvastatin |
Atorvistat K |
Film coated tablet |
10 |
mg |
30 |
Софарма АД, България |
20 |
mg |
- |
4.8 |
0.08333 |
1.25 |
25% |
0.31 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
КЦРР-2742/20.03.2013 г.; НСР-8528/16.03.2016; НСР-18406/05.04.2019 |
02.05.2019 |
|
|
Активен |
1768 |
| C10AA05 |
Atorvastatin |
Avanor |
Film coated tablet |
10 |
mg |
30 |
Teva B.V., Нидерландия |
20 |
mg |
- |
2.18 |
0.08333 |
1.25 |
25% |
0.31 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
КЦРР-2970/20.03.2013 г.; НСР-3697/06.06.2014; HCP-9005/14.04.2016; НСР-16171/13.07.2018; КП-21/18.02.2019 и НСР-168158/20.09.2018 |
02.04.2019 |
|
|
Активен |
2906 |
| C10AA05 |
Atorvastatin |
Avanor |
Film coated tablet |
20 |
mg |
30 |
Teva B.V., Нидерландия |
20 |
mg |
- |
2.5 |
0.08333 |
2.5 |
25% |
0.62 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
КЦРР-2970/20.03.2013 г; НСР-2295/13.01.2014; НСР-5961/01.04.2015.; HCP-9004/14.04.2016.; НСР-13044/23.06.2017; НСР-16530/17.08.2018 |
02.09.2018 |
|
|
Активен |
964 |
| C10AA05 |
Atorvastatin |
Calipra |
Film coated tablet |
40 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
20 |
mg |
- |
10.42 |
0.08333 |
5 |
25% |
1.25 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
HCP-10139/30.08.2016; НСР-14464/17.11.2017; НСР-17993/21.02.2019 |
02.04.2019 |
|
|
Активен |
15391 |
| C10AA05 |
Atorvastatin |
Calipra |
Film coated tablet |
20 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
20 |
mg |
- |
6.71 |
0.08333 |
2.5 |
25% |
0.62 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
HCP-10139/30.08.2016 |
02.08.2017 |
|
|
Активен |
15390 |
| C10AA05 |
Atorvastatin |
Calipra |
Film coated tablet |
80 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
20 |
mg |
- |
14.32 |
0.08333 |
10 |
25% |
2.5 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-10139/30.09.2016 |
02.08.2017 |
|
|
Активен |
15392 |
| C10AA05 |
Atorvastatin |
Calipra |
Film coated tablet |
10 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
20 |
mg |
- |
4.93 |
0.08333 |
1.25 |
25% |
0.31 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
HCP-10139/30.08.2016 |
02.08.2017 |
|
|
Активен |
15389 |
| C10AA05 |
Atorvastatin |
Calipra |
Film coated tablet |
80 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
20 |
mg |
- |
19.33 |
0.12033 |
14.44 |
25% |
3.61 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-805/07.08.2013; НСР-2056/11.12.2013 |
16.01.2014 |
|
|
Заличен |
2078 |
| C10AA05 |
Atorvastatin |
Calipra |
Film coated tablet |
40 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
20 |
mg |
- |
17.29 |
0.12033 |
7.22 |
25% |
1.81 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-805/07.08.2013; НСР-2055/11.12.2013 |
16.01.2014 |
|
|
Заличен |
2077 |
| C10AA05 |
Atorvastatin |
Calipra |
Film coated tablet |
20 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
20 |
mg |
- |
14.65 |
0.12033 |
3.61 |
25% |
0.9 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-805/07.08.2013; НСР-2054/11.12.2013 |
16.01.2014 |
|
|
Заличен |
2076 |
| C10AA05 |
Atorvastatin |
Calipra |
Film coated tablet |
10 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
20 |
mg |
- |
9.76 |
0.12033 |
1.81 |
25% |
0.45 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-805/07.08.2013; НСР-2053/11.12.2013 |
16.01.2014 |
|
|
Заличен |
2075 |
| C10AA05 |
Atorvastatin |
LARUS |
Film coated tablet |
10 |
mg |
30 |
Gedeon Richter Plc., Унгария |
20 |
mg |
- |
4.8 |
0.10933 |
1.64 |
25% |
0.41 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№ 117/10.11.2010; КЦРР-1283/21.08.2012 г.; НСР-528/11.07.2013; НСР-5345/18.12.2014. |
16.01.2015 |
08.09.2012 |
|
Заличен |
1983 |
| C10AA05 |
Atorvastatin |
LARUS |
Film coated tablet |
20 |
mg |
30 |
Gedeon Richter Plc., Унгария |
20 |
mg |
- |
7.18 |
0.10933 |
3.28 |
25% |
0.82 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№ 66/ 08.04.2010; № 84/27.05.2010; КЦРР-1283/21.08.2012 г.; НСР-527/11.07.2013; НСР-4961/29.10.2014 |
16.11.2014 |
08.09.2012 |
|
Заличен |
1982 |
| C10AA05 |
Atorvastatin |
SORTIS |
Film coated tablet |
40 |
mg |
30 |
Pfizer Europe MA EEIG, Белгия |
20 |
mg |
- |
15.19 |
0.08333 |
5 |
25% |
1.25 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
КЦРР-1032/23.07.2012 г.; НСР-2337/13.01.2014; НСР-5947/01.04.2015.; НСР-12958/15.06.2017; НСР-16573/24.08.2018; НСР-17480/13.12.2018 |
02.01.2019 |
08.09.2012 |
|
Активен |
3721 |
| C10AA05 |
Atorvastatin |
SORTIS |
Film coated tablet |
20 |
mg |
30 |
Pfizer Europe MA EEIG, Обединено Кралство |
20 |
mg |
- |
18.12 |
0.08333 |
2.5 |
25% |
0.62 |
|
I20.0,I20.1,I20.8,I20.9,I25.5,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
КЦРР-1032/23.07.2012 г.; НСР-2337/13.01.2014; НСР-5946/01.04.2015.; НСР-16214/19.07.2018 |
02.09.2018 |
08.09.2012 |
|
Заличен |
3720 |